News
BMRA
1.610
+1.58%
0.025
Weekly Report: what happened at BMRA last week (0810-0814)?
Weekly Report · 5d ago
Weekly Report: what happened at BMRA last week (0803-0807)?
Weekly Report · 08/10 09:07
Weekly Report: what happened at BMRA last week (0727-0731)?
Weekly Report · 08/03 09:07
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 07/30 12:06
Weekly Report: what happened at BMRA last week (0720-0724)?
Weekly Report · 07/27 09:07
Weekly Report: what happened at BMRA last week (0713-0717)?
Weekly Report · 07/20 09:07
Weekly Report: what happened at BMRA last week (0706-0710)?
Weekly Report · 07/13 09:07
Weekly Report: what happened at BMRA last week (0629-0703)?
Weekly Report · 07/06 09:08
Weekly Report: what happened at BMRA last week (0622-0626)?
Weekly Report · 06/29 09:07
Weekly Report: what happened at BMRA last week (0615-0619)?
Weekly Report · 06/22 09:08
Weekly Report: what happened at BMRA last week (0608-0612)?
Weekly Report · 06/15 09:08
Weekly Report: what happened at BMRA last week (0601-0605)?
Weekly Report · 06/08 09:08
Biomerica Enters Related-Party Deal to Boost Liquidity
TipRanks · 06/04 22:51
Weekly Report: what happened at BMRA last week (0525-0529)?
Weekly Report · 06/01 09:08
Biomerica Enters Service Agreement To Develop IVD Assays
NASDAQ · 05/29 14:14
Biomerica enters master services agreement with life sciences company
TipRanks · 05/28 15:16
Weekly Report: what happened at BMRA last week (0518-0522)?
Weekly Report · 05/25 09:08
Weekly Report: what happened at BMRA last week (0511-0515)?
Weekly Report · 05/18 09:08
Weekly Report: what happened at BMRA last week (0504-0508)?
Weekly Report · 05/11 09:08
Weekly Report: what happened at BMRA last week (0427-0501)?
Weekly Report · 05/04 09:08
More
Webull provides a variety of real-time BMRA stock news. You can receive the latest news about Biomerica Inc through multiple platforms. This information may help you make smarter investment decisions.
About BMRA
Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products. Its diagnostic test kits are used to analyze blood, urine, nasal, or fecal material from patients in the diagnosis of various diseases, food intolerances, and other medical complications. The Company’s diagnostic test kits can also be used to measure or detect the presence and levels of specific bacteria, hormones, antibodies, antigens and other substances, which may exist in the human body in small concentrations. Its range of medical diagnostic products is sold in two markets: clinical laboratories and point-of-care settings. The Company’s diagnostic-guided therapy (DGT) product is developed on the inFoods technology platform, which is designed to aid in the management of gastrointestinal conditions such as irritable bowel syndrome (IBS) and other inflammatory diseases.